Infliximab therapy provides beneficial effects for choroidal thickness increase in patients with active ankylosing spondylitis: A possible mechanism mediating the suppressing of uveitis attacks

Creative Commons License

KARKUCAK M., KOLA M., Kalkisim A., ÇAPKIN E., AYAR A., TÜRK A.

ARCHIVES OF RHEUMATOLOGY, vol.36, no.1, pp.56-62, 2021 (SCI-Expanded) identifier identifier identifier

  • Publication Type: Article / Article
  • Volume: 36 Issue: 1
  • Publication Date: 2021
  • Doi Number: 10.46497/archrheumatol.2021.7806
  • Journal Name: ARCHIVES OF RHEUMATOLOGY
  • Journal Indexes: Science Citation Index Expanded (SCI-EXPANDED), Scopus, Academic Search Premier, CINAHL, EMBASE, TR DİZİN (ULAKBİM)
  • Page Numbers: pp.56-62
  • Keywords: Ankylosing spondylitis, choroid thickness, infliximab, optical coherence tomography, retinal nerve fiber layer thickness, OPTICAL COHERENCE TOMOGRAPHY, NERVE-FIBER LAYER, ARTERIAL STIFFNESS, ALPHA THERAPY, RECOMMENDATIONS, ASSOCIATION, EYES
  • Karadeniz Technical University Affiliated: Yes

Abstract

Objectives: This study aims to quantitatively assess the profile of the choroidal thickness (ChT) in patients with ankylosing spondylitis (AS) using optical coherence tomography (OCT), and to examine whether the posterior eye segment abnormalities in active AS patients are reversible by infliximab therapy.